Pharma had its run, start picking up cyclicals:…

Our fundamental thesis is for a robust recovery in the global economy over the next one year, whereby cyclicals will perform well. We would be very interested in base metals, materials and cement stocks, says…

Despite a sectoral trend, it pays to be…

You have to look at companies benefiting vis-à-vis competition which is the only sustainability of this share price or fundamentals momentum, says Portfolio Manager, Marcellus Investment Managers. Is your portfolio smiling and mirroring what is…

Will the launch of Favipiravir mark the turnaround…

Glenmark Pharma last week became the first Indian company to receive approval for manufacture and marketing of Favipiravir for the treatment of mild-to-moderate symptoms of Covid-19, in what is a positive development for the investors…

Glenmark Pharma shares jump nearly 9% on DCGI…

New Delhi: Shares of Glenmark Pharmaceuticals on Thursday gained nearly 9 per cent after the company said it has received approval from DCGI to conduct clinical trials of tablets used for the treatment of COVID-19…